Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,807.20
-20.30 (-1.11%)
Nov 12, 2026, 3:29 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 1.04 trillion as of November 12, 2026. It is the 1,989th most valuable company in the world and the 116th biggest in India. Its market cap has increased by 53.25% in one year.
Market Cap
1.04T
Enterprise Value
1.03T
Revenue
369.13B
Global Rank
Country Rank
#116 India
PE Ratio
26.18
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 1.04T, an increase of 10,727.80%. That is a compound annual growth rate of 21.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.04T | 51.34% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 3.07T |
| Laurus Labs | 1.33T |
| Zydus Lifesciences | 1.21T |
| Cipla | 1.13T |
| Mankind Pharma | 1.10T |
| Glenmark Pharmaceuticals | 753.79B |
| Alkem Laboratories | 645.47B |
| Gland Pharma | 541.92B |